# Using a Centralized IRB Review Process in Multicenter Clinical Trials:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/using-a-centralized-irb-review-process-in-multicenter-clinical-trials-guidance-for-industry/ee43606d-42ae-49fd-904c-0cd676da114b

> FDA guidance document: Using a Centralized IRB Review Process in Multicenter Clinical Trials:  Guidance for Industry. Issue date: March 16, 2006. Get complete insights and analysis.

---

## Details

- Title: Using a Centralized IRB Review Process in Multicenter Clinical Trials:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2006-03-16
- Last Changed: 2023-09-29
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2005-D-0443">FDA-2005-D-0443</a>

## Related Documents

- [Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations](https://www.globalkeysolutions.net/guidances/guidance-document/quality-systems-approach-to-pharmaceutical-current-good-manufacturing-practice-regulations/9ed0e9b2-d08c-4cb7-b5fd-6cd0b3699b31)
- [Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/sterile-drug-products-produced-by-aseptic-processing-current-good-manufacturing-practice-guidance-for-industry/0404765b-fedd-4d75-91f6-24f8781614ad)
- [Current Good Manufacturing Practice for Phase 1 Investigational Drugs:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/current-good-manufacturing-practice-for-phase-1-investigational-drugs-guidance-for-industry/179f8504-7c99-4bec-826e-e67ad9ce1f79)